Regeneron Pharmaceuticals Inc (REGN)

611.22
-4.02(-0.65%)
After Hours
613.00
+1.78(+0.29%)
- Real-time Data
  • Volume:
    974,427
  • Bid/Ask:
    598.01/630.00
  • Day's Range:
    598.13 - 612.39

REGN Overview

Prev. Close
615.24
Day's Range
598.13-612.39
Revenue
13.54B
Open
604.52
52 wk Range
441.3-686.62
EPS
62.64
Volume
974,427
Market Cap
63.91B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
741,290
P/E Ratio
9.76
Beta
0.19
1-Year Change
18.01%
Shares Outstanding
104,555,539
Next Earnings Date
03 Feb 2022
What is your sentiment on Regeneron Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Regeneron Pharmaceuticals Inc Company Profile

Employees
9766

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company's commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. It is also engaged in the research, development of monoclonal antibodies, which consists of Dupixent, Kevzara, and itepekimab. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, Kevzara (sarilumab) Solution for Subcutaneous Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellBuy
Technical IndicatorsStrong BuyStrong BuySellStrong SellStrong Buy
SummaryStrong BuyStrong BuySellStrong SellStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.